Drug Type Fusion protein |
Synonyms |
Mechanism FGF21 agonists(Fibroblast growth factor 21 agonists), GCGR agonists(Glucagon receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Onegene BiotechnologyStartup |
Active Organization Onegene BiotechnologyStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | KR | Onegene BiotechnologyStartup | 30 Jan 2022 |
Idiopathic Pulmonary Fibrosis | Preclinical | KR | Onegene BiotechnologyStartup | 30 Jan 2022 |
Nonalcoholic Steatohepatitis | Preclinical | KR | Onegene BiotechnologyStartup | 30 Jan 2022 |